Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Total Non-Current Liabilities: 2022

Historic Total Non-Current Liabilities for Therapeutics (LENZ) over the last 1 years, with Dec 2022 value amounting to $14.8 million.

  • Therapeutics' Total Non-Current Liabilities was N/A to $32.9 million in Q1 2023 from the same period last year, while for Mar 2023 it was $32.9 million, marking a year-over-year change of. This contributed to the annual value of $14.8 million for FY2022, which is N/A change from last year.
  • Latest data reveals that Therapeutics reported Total Non-Current Liabilities of $14.8 million as of FY2022.
  • Therapeutics' Total Non-Current Liabilities' 5-year high stood at $14.8 million during FY2022, with a 5-year trough of $14.8 million in FY2022.
  • Over the past 1 years, Therapeutics' median Total Non-Current Liabilities value was $14.8 million (recorded in 2022), while the average stood at $14.8 million.